Rating History for Nektar Therapeutics (NKTR) by Canaccord
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 7/22/2026 | Edward Nash | New Coverage | Buy (N/A) |
153.00 (N/A) |
68.67 (70.77) |
3.06% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 7/22/2026 | Edward Nash | New Coverage | Buy (N/A) |
153.00 (N/A) |
68.67 (70.77) |
3.06% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||